Interestingly, increased donor engraftment and event-free survival following the addition of G-CSF/AMD3100 to the conditioning regimen of Wiskott-Aldrich syndrome patients undergoing allogenic HCT have been reported (Balashov et al., 2018). Here, CSF3 is linked to Wiskott-Aldrich syndrome.